Surmodics Revenue 2010-2025 | SRDX
Surmodics revenue from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Surmodics Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $126 |
| 2023 | $133 |
| 2022 | $100 |
| 2021 | $105 |
| 2020 | $95 |
| 2019 | $100 |
| 2018 | $81 |
| 2017 | $73 |
| 2016 | $71 |
| 2015 | $62 |
| 2014 | $57 |
| 2013 | $56 |
| 2012 | $52 |
| 2011 | $53 |
| 2010 | $54 |
| 2009 | $122 |
| Surmodics Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2025-03-31 | $28 |
| 2024-12-31 | $30 |
| 2024-09-30 | $33 |
| 2024-06-30 | $30 |
| 2024-03-31 | $32 |
| 2023-12-31 | $31 |
| 2023-09-30 | $28 |
| 2023-06-30 | $52 |
| 2023-03-31 | $27 |
| 2022-12-31 | $25 |
| 2022-09-30 | $26 |
| 2022-06-30 | $25 |
| 2022-03-31 | $26 |
| 2021-12-31 | $23 |
| 2021-09-30 | $24 |
| 2021-06-30 | $24 |
| 2021-03-31 | $35 |
| 2020-12-31 | $22 |
| 2020-09-30 | $23 |
| 2020-06-30 | $27 |
| 2020-03-31 | $23 |
| 2019-12-31 | $23 |
| 2019-09-30 | $31 |
| 2019-06-30 | $24 |
| 2019-03-31 | $23 |
| 2018-12-31 | $22 |
| 2018-09-30 | $23 |
| 2018-06-30 | $22 |
| 2018-03-31 | $19 |
| 2017-12-31 | $17 |
| 2017-09-30 | $20 |
| 2017-06-30 | $18 |
| 2017-03-31 | $18 |
| 2016-12-31 | $18 |
| 2016-09-30 | $18 |
| 2016-06-30 | $20 |
| 2016-03-31 | $17 |
| 2015-12-31 | $17 |
| 2015-09-30 | $17 |
| 2015-06-30 | $16 |
| 2015-03-31 | $14 |
| 2014-12-31 | $14 |
| 2014-09-30 | $15 |
| 2014-06-30 | $15 |
| 2014-03-31 | $14 |
| 2013-12-31 | $14 |
| 2013-09-30 | $14 |
| 2013-06-30 | $14 |
| 2013-03-31 | $14 |
| 2012-12-31 | $14 |
| 2012-09-30 | $14 |
| 2012-06-30 | $14 |
| 2012-03-31 | $12 |
| 2011-12-31 | $12 |
| 2011-09-30 | $14 |
| 2011-06-30 | $13 |
| 2011-03-31 | $13 |
| 2010-12-31 | $13 |
| 2010-09-30 | $16 |
| 2010-06-30 | $19 |
| 2010-03-31 | $18 |
| 2009-12-31 | $17 |
| 2009-09-30 | $19 |
| 2009-06-30 | $18 |
| 2009-03-31 | $21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.446B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.206B | 27.56 |
| Boston Scientific (BSX) | United States | $152.664B | 38.22 |
| Stryker (SYK) | United States | $149.191B | 31.19 |
| EssilorLuxottica (ESLOY) | France | $131.913B | 0.00 |
| Medtronic (MDT) | Ireland | $115.147B | 16.32 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.094B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.531B | 24.85 |
| ResMed (RMD) | United States | $37.280B | 28.00 |
| GE HealthCare Technologies (GEHC) | United States | $34.547B | 16.40 |
| Agilent Technologies (A) | United States | $32.221B | 21.01 |
| Terumo (TRUMY) | Japan | $24.355B | 31.64 |
| Koninklijke Philips (PHG) | Netherlands | $23.476B | 16.47 |
| Insulet (PODD) | United States | $20.287B | 79.63 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.641B | 11.97 |
| Baxter (BAX) | United States | $14.559B | 10.87 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.951B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.729B | 23.42 |
| Lantheus Holdings (LNTH) | United States | $5.148B | 12.99 |
| Perrigo (PRGO) | Ireland | $3.724B | 9.44 |
| Prestige Consumer Healthcare (PBH) | United States | $3.715B | 16.59 |
| Haemonetics (HAE) | United States | $3.575B | 16.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.342B | 27.77 |
| ICU Medical (ICUI) | United States | $3.072B | 22.66 |
| LeMaitre Vascular (LMAT) | United States | $1.867B | 41.72 |
| QuidelOrtho (QDEL) | United States | $1.864B | 12.82 |
| AtriCure (ATRC) | United States | $1.504B | 0.00 |
| Acuren (TIC) | United States | $1.431B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.238B | 15.82 |
| AdaptHealth (AHCO) | United States | $1.232B | 12.51 |
| Green Thumb Industries (GTBIF) | United States | $1.212B | 27.26 |
| Neogen (NEOG) | United States | $1.068B | 13.67 |
| BioLife Solutions (BLFS) | United States | $1.006B | 0.00 |
| InMode (INMD) | Israel | $0.901B | 9.08 |
| Kestra Medical Technologies (KMTS) | United States | $0.788B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.08 |
| Tilray Brands (TLRY) | Canada | $0.607B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| CeriBell (CBLL) | United States | $0.571B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| SNDL (SNDL) | Canada | $0.392B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.331B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.321B | 11.82 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.300B | 0.00 |
| Quanterix (QTRX) | United States | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.30 |
| Cresco Labs (CRLBF) | United States | $0.260B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.67 |
| Sanara MedTech (SMTI) | United States | $0.248B | 0.00 |
| ZimVie (ZIMV) | United States | $0.243B | 11.04 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| Brainsway (BWAY) | Israel | $0.230B | 60.75 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| Omeros (OMER) | United States | $0.206B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.202B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.197B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.87 |
| TriSalus Life Sciences (TLSI) | United States | $0.178B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.152B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.16 |
| TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.87 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 14.76 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 49.29 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |